ACE gene polymorphism in peripheral vascular disease

Hormone and Metabolic Research

Volumn 39, Issue 7, 2007, Pages 534-537

  Basar Y ^a   Salmayenli, N ^a   Aksoy, M ^a   Seckin S ^a   Aydin, M ^b   Ozkok E ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting; Enzyme; Genotype; Peripheral vascular disease; Polymorphism; Serum

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, GENETIC;

EID: 34547627869     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-982529     Document Type: Article

References (15)

1. Baudin B. New aspects on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med 2002; 40: 256-265
2. Pilati M, Cicoira M, Zanolla L, Nicoletti I, Muraglia S, Zardini P. The role of angiotensin-converting enzyme polymorphism in congestive heart failure. Congest Heart Fail 2004; 10: 87-93
3. Hooper WC, Dowling NF, Wenger NK, Dilley A, Ellingsen D, Evatt BL. Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans. Am J Hematol 2002; 70: 1-8
4. Tseng CH, Tseng CP. Lack of association between angiotensin-converting enzyme gene polymorphism and peripheral vascular disease in type 2 diabetic patients in Taiwan. Circ J 2002; 66: 1014-1018
5. Kawamoto R, Kohara K, Tabara Y, Miki T. An interaction between systolic pressure and angiotensin-converting enzyme gene polymorphism on carotid atherosclerosis. Hypertens Res 2002; 25: 875-880
6. Hessner MJ, Dinauer DM, Kwiatkowski R, Neri B, Raife TJ. Age-dependent prevalence of vascular disease-associated polymorphisms among 2689 volunteer blood donors. Clin Chem 2001; 47: 1879-1884
7. Taute BM, Seifert H, Taute R, Glaser C, Podhaisky H. Angiotensin-converting enzyme gene insertion/deletion polymorphism and carotid artery wall thickness in patients' peripheral arterial occlusive disease. Int Angiol 2000; 19: 337-344
8. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16: 1215
9. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptdyl carboxypeptidase). Nucl Acids Res 1992; 20: 1433
10. Wiwanitkit V. Angiotensin-converting enzyme gene polymorphism: I and 1 from some different countries. Clin Appl Thromb Hemost 2004; 10: 179-182
11. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H et al. The D allele of the angiotensin-converting enzyme insertion/deletion (I/D) polymorphism is a risk factor for type 2 diabetes in a population-based Japanese sample. Endocr J 2003; 50: 393-398
12. Molnar GA, Wagner Z, Wagner I, Melegh B, Koszegi T, Degrell P et al. Effect of ACE gene polymorphism on carbohydrate metabolism on oxidative stress and on end-organ damage in type-2 diabetes mellitus. Orv Hetil 2004; 145: 855-859
13. Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC. Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 2003; 20: 988-995
14. Renner W, Pabst E, Paulweber B, Malaimare L, Iglseder B, Wascher TC et al. The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for peripheral arterial disease. Atherosclerosis 2002; 165: 175-178
15. Qadar Pasha MA, Khan AP, Kumar R, Ram RB, Grover SK, Srivastava KK et al. Variations in angiotensin-converting enzyme gene insertion/ deletion polymorphism in Indian populations of different ethnic origins. J Biosci 2002; 27 (Suppl 1): 67-70